Skip to Main Content

Author Details

Mary Anne Rossing
Fred Hutchinson Cancer Research Center
1989
175
50
PMIDPaper TitleJournal TitlePublished Year
34789471High Prediagnosis Inflammation-Related Risk Score Associated with Decreased Ovarian Cancer Survival.Cancer Epidemiol Biomarkers Prev2022
32546565Population-based targeted sequencing of 54 candidate genes identifies <i>PALB2</i> as a susceptibility gene for high-grade serous ovarian cancer.J Med Genet2021
33990587Author Correction: A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers.Nat Commun2021
32766851Expanding Our Understanding of Ovarian Cancer Risk: The Role of Incomplete Pregnancies.J Natl Cancer Inst2021
32239218Association Between Breastfeeding and Ovarian Cancer Risk.JAMA Oncol2020
32028322Estrogen Plus Progestin Hormone Therapy and Ovarian Cancer: A Complicated Relationship Explored.Epidemiology2020
32641237Menopausal hormone therapy prior to the diagnosis of ovarian cancer is associated with improved survival.Gynecol Oncol2020
32554541Development and Validation of the Gene Expression Predictor of High-grade Serous Ovarian Carcinoma Molecular SubTYPE (PrOTYPE).Clin Cancer Res2020
32473302Prognostic gene expression signature for high-grade serous ovarian cancer.Ann Oncol2020
29718305Invasive Epithelial Ovarian Cancer Survival by Histotype and Disease Stage.J Natl Cancer Inst2019
31211375Association between genetically predicted polycystic ovary syndrome and ovarian cancer: a Mendelian randomization study.Int J Epidemiol2019
31548585Publisher Correction: Shared heritability and functional enrichment across six solid cancers.Nat Commun2019
31001917Evaluation of vitamin D biosynthesis and pathway target genes reveals UGT2A1/2 and EGFR polymorphisms associated with epithelial ovarian cancer in African American Women.Cancer Med2019
30499236A comprehensive gene-environment interaction analysis in Ovarian Cancer using genome-wide significant common variants.Int J Cancer2019
30683880Shared heritability and functional enrichment across six solid cancers.Nat Commun2019
28633381Robust Tests for Additive Gene-Environment Interaction in Case-Control Studies Using Gene-Environment Independence.Am J Epidemiol2018
30134598rs495139 in the TYMS-ENOSF1 Region and Risk of Ovarian Carcinoma of Mucinous Histology.Int J Mol Sci2018
30054336A Transcriptome-Wide Association Study Among 97,898 Women to Identify Candidate Susceptibility Genes for Epithelial Ovarian Cancer Risk.Cancer Res2018
30121132Histotype classification of ovarian carcinoma: A comparison of approaches.Gynecol Oncol2018
30062862Association of p16 expression with prognosis varies across ovarian carcinoma histotypes: an Ovarian Tumor Tissue Analysis consortium study.J Pathol Clin Res2018
29979793Variants in genes encoding small GTPases and association with epithelial ovarian cancer susceptibility.PLoS One2018
29555990Adult height is associated with increased risk of ovarian cancer: a Mendelian randomisation study.Br J Cancer2018
29584862Racial/ethnic differences in the epidemiology of ovarian cancer: a pooled analysis of 12 case-control studies.Int J Epidemiol2018
29247577Ovarian cancer risk, ALDH2 polymorphism and alcohol drinking: Asian data from the Ovarian Cancer Association Consortium.Cancer Sci2018
29141849Polycystic Ovary Syndrome, Oligomenorrhea, and Risk of Ovarian Cancer Histotypes: Evidence from the Ovarian Cancer Association Consortium.Cancer Epidemiol Biomarkers Prev2018
29211900Racial/ethnic differences in the epidemiology of ovarian cancer: a pooled analysis of 12 case-control studies.Int J Epidemiol2018
28833087Menstrual pain and risk of epithelial ovarian cancer: Results from the Ovarian Cancer Association Consortium.Int J Cancer2018
28063166Cigarette smoking is associated with adverse survival among women with ovarian cancer: Results from a pooled analysis of 19 studies.Int J Cancer2017
28103614Enrichment of putative PAX8 target genes at serous epithelial ovarian cancer susceptibility loci.Br J Cancer2017
28350790Use of common analgesic medications and ovarian cancer survival: results from a pooled analysis in the Ovarian Cancer Association Consortium.Br J Cancer2017
28293802History of hypertension, heart disease, and diabetes and ovarian cancer patient survival: evidence from the ovarian cancer association consortium.Cancer Causes Control2017
28346442Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.Nat Genet2017
28699174Inherited variation in circadian rhythm genes and risks of prostate cancer and three other cancer sites in combined cancer consortia.Int J Cancer2017
28864456History of Comorbidities and Survival of Ovarian Cancer Patients, Results from the Ovarian Cancer Association Consortium.Cancer Epidemiol Biomarkers Prev2017
28817835History of thyroid disease and survival of ovarian cancer patients: results from the Ovarian Cancer Association Consortium, a brief report.Br J Cancer2017
27677730No Evidence That Genetic Variation in the Myeloid-Derived Suppressor Cell Pathway Influences Ovarian Cancer Survival.Cancer Epidemiol Biomarkers Prev2017
28035019Integration of Population-Level Genotype Data with Functional Annotation Reveals Over-Representation of Long Noncoding RNAs at Ovarian Cancer Susceptibility Loci.Cancer Epidemiol Biomarkers Prev2017
27941069Pelvic Inflammatory Disease and the Risk of Ovarian Cancer and Borderline Ovarian Tumors: A Pooled Analysis of 13 Case-Control Studies.Am J Epidemiol2017
25940428No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer.Gynecol Oncol2016
27698005Risk Prediction for Epithelial Ovarian Cancer in 11 United States-Based Case-Control Studies: Incorporation of Epidemiologic Risk Factors and 17 Confirmed Genetic Loci.Am J Epidemiol2016
27601076Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast-ovarian cancer susceptibility locus.Nat Commun2016
27595995PALB2, CHEK2 and ATM rare variants and cancer risk: data from COGS.J Med Genet2016
27911851Inherited variants affecting RNA editing may contribute to ovarian cancer susceptibility: results from a large-scale collaboration.Oncotarget2016
27594614Association of vitamin D levels and risk of ovarian cancer: a Mendelian randomization study.Int J Epidemiol2016
27533245Assessment of variation in immunosuppressive pathway genes reveals TGFBR2 to be associated with risk of clear cell ovarian cancer.Oncotarget2016
27299959Recreational physical inactivity and mortality in women with invasive epithelial ovarian cancer: evidence from the Ovarian Cancer Association Consortium.Br J Cancer2016
27420401A splicing variant of TERT identified by GWAS interacts with menopausal estrogen therapy in risk of ovarian cancer.Int J Cancer2016
27197285Chronic Recreational Physical Inactivity and Epithelial Ovarian Cancer Risk: Evidence from the Ovarian Cancer Association Consortium.Cancer Epidemiol Biomarkers Prev2016
27378695Exome genotyping arrays to identify rare and low frequency variants associated with epithelial ovarian cancer risk.Hum Mol Genet2016
27401727Adult body mass index and risk of ovarian cancer by subtype: a Mendelian randomization study.Int J Epidemiol2016
  • 1 - 50 of 175

Recommended Authors

Boston University Chobanian & Avedisian School of Medicine
Career Start Year 2011
Number of shared co-authors 19
University of California San Diego
Career Start Year 2008
Number of shared co-authors 1
Mailman School of Public Health, Columbia University
Career Start Year 2001
Number of shared co-authors 16
Hospital of the University of Pennsylvania
Career Start Year 1999
Number of shared co-authors 1
University of Virginia, Emily Couric Clinical Cancer Center
Career Start Year 1998
Number of shared co-authors 5
Southern California Permanente Medical Group
Career Start Year 1998
Number of shared co-authors 2
National Institutes of Health
Career Start Year 1998
Number of shared co-authors 6
Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center
Career Start Year 1998
Number of shared co-authors 60
Beckman Research Institute of City of Hope
Career Start Year 1997
Number of shared co-authors 71
University of Colorado Anschutz Medical Campus
Career Start Year 1996
Number of shared co-authors 2
Center for Health Research, Kaiser Permanente Northwest Research Center
Career Start Year 1994
Number of shared co-authors 7
Institut de Recherche en Cancerologie de Montpellier
Career Start Year 1993
Number of shared co-authors 17
Inc. San Carlos
Career Start Year 1993
Number of shared co-authors 41
Women's Health Integrated Research Center, Inova Health System
Career Start Year 1992
Number of shared co-authors 66
Fred Hutchinson Cancer Research Center
Career Start Year 1991
Number of shared co-authors 12
Harvard T.H. Chan School of Public Health
Career Start Year 1990
Number of shared co-authors 83
National Cancer Institute.
Career Start Year 1990
Number of shared co-authors 39
National Human Genome Research Institute, National Institutes of Health
Career Start Year 1988
Number of shared co-authors 44
Laval University
Career Start Year 1986
Number of shared co-authors 2
Kaiser Permanente Northern California, University of California san francisco
Career Start Year 1985
Number of shared co-authors 58
University at Buffalo
Career Start Year 1984
Number of shared co-authors 6
University of North Carolina at Chapel Hill
Career Start Year 1983
Number of shared co-authors 35
Keck School of Medicine, University of Southern California
Career Start Year 1981
Number of shared co-authors 13
National Cancer Institute, 9609 Medical Center Dr
Career Start Year 1981
Number of shared co-authors 82
Albert Einstein College of Medicine
Career Start Year 1980
Number of shared co-authors 51
Washington University School of Medicine
Career Start Year 1978
Number of shared co-authors 58
National Cancer Institute
Career Start Year 1977
Number of shared co-authors 40
Ontario Institute for Cancer Research
Career Start Year 1974
Number of shared co-authors 6
University of California San Francisco
Career Start Year 1968
Number of shared co-authors 18
National Cancer Institute
Career Start Year 1959
Number of shared co-authors 67

Collaborators

Huntsman Cancer Institute, University of Utah
Co-authored papers 112
Rollins School of Public Health, Emory University
Co-authored papers 96
University of Southern California
Co-authored papers 94
University of Michigan School of Public Health ann arbor
Co-authored papers 93
Duke School of Medicine
Co-authored papers 93
Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center
Co-authored papers 92
Mayo Clinic College of Medicine
Co-authored papers 79
School of Clinical Medicine, University of NSW Sydney, Lowy Cancer Research Centre
Co-authored papers 78
German Cancer Research Center (DKFZ)
Co-authored papers 77
Cedars-Sinai Medical Center
Co-authored papers 77
University of California irvine
Co-authored papers 76
College of Nursing, University of South Florida
Co-authored papers 74
Center for Cancer Genetic Epidemiology, University of Cambridge
Co-authored papers 73
Memorial Sloan-Kettering Cancer Center
Co-authored papers 71
UCL EGA Institute for Women's Health, University College London
Co-authored papers 71
Co-authored papers 70
Co-authored papers 62
University of Cambridge
Co-authored papers 62
National Cancer Institute, National Institutes of Health
Co-authored papers 60
QIMR Berghofer Medical Research Institute
Co-authored papers 60
Co-authored papers 59
H. Lee Moffitt Cancer Center and Research Institute
Co-authored papers 56
Otto-Friedrich-University Bamberg
Co-authored papers 52
International Hereditary Cancer Center, Pomeranian Medical University
Co-authored papers 50
Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center
Co-authored papers 50
Co-authored papers 48
David Geffen School of Medicine, University of California los angeles
Co-authored papers 48
Perlmutter Cancer Center
Co-authored papers 47
Pomeranian Medical University
Co-authored papers 47
The M. Sklodowska-Curie Cancer Center and Institute of Oncology
Co-authored papers 46